Compares treatment options for Vitamin Deficiencies
Official title Trial Comparing Elan Specialized Bariatric Supplements With Standard Multivitamins in Patients Undergoing Bariatric Procedures
ClinicalTrials.gov ID: NCT07021170
What this study is testing
- What it's testing
- Obesity has escalated to pandemic levels, impacting over 650 million adults globally and significantly contributing to the burden of non-communicable diseases such as type 2 diabetes, cardiovascular disease, obstructive sleep apnea, non-alcoholic fatty liver disease, and infertility. The chronic, multifactorial nature of obesity presents substantial challenges for long-term management, as lifestyle modifications and pharmacotherapy often yield limited and transient success.
- Phase 4: studies an already-approved treatment
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Eligible participants must be adults:
- Aged 18 to 65 years
- Capable of providing informed consent
- Willing to comply with study procedures and follow-up visits over 12 months.
- Candidates must have no prior history of MBS or gastrointestinal surgery and must be scheduled for one of the three aforementioned primary procedures.
You likely can't join if
- Exclusion criteria include:
- The presence of chronic conditions that may independently affect micronutrient metabolism or absorption, such as chronic kidney disease, inflammatory...
- Additional exclusion criteria include pregnancy or lactation at the time of enrollment
- Plans for pregnancy within the study period
- Active malignancy
- Any use of investigational drugs or supplements within the past 30 days.
See the full eligibility criteria
- Eligible participants must be adults:
- Aged 18 to 65 years
- Capable of providing informed consent
- Willing to comply with study procedures and follow-up visits over 12 months.
- Candidates must have no prior history of MBS or gastrointestinal surgery and must be scheduled for one of the three aforementioned primary procedures.
- Both male and female patients will be considered, and no restrictions will be placed based on ethnicity or socioeconomic status.
- Exclusion criteria include:
- The presence of chronic conditions that may independently affect micronutrient metabolism or absorption, such as chronic kidney disease, inflammatory bowel disease, or hepatic insufficiency.
- Additional exclusion criteria include pregnancy or lactation at the time of enrollment
- Plans for pregnancy within the study period
- Active malignancy
- Any use of investigational drugs or supplements within the past 30 days.
- Patients undergoing revisional bariatric surgery or conversion procedures will also be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Alexandria Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Alexandria Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.